Delivery Order SPE2DB22D1041-SPE2DB25FUBL7
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,622.82 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for ultimate completion by June 18, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $45,433.69 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $83,524.51 on July 22, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,695.65 on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of September 11, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a continuation of...
- The Defense Logistics Agency awarded a $5,013.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,532.48 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on August 29, 2025. This firm fixed-price, competitively awarded contract is scheduled for completion by September 2, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $12,579.89 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count) on September 8, 2025, with completion scheduled for September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, the contract was competitively procured, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,718.16 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units). This firm fixed-price delivery order, awarded on July 31, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $33,369.67 to supply Entresto 24 mg-26 mg tablets (180-count units). This non-competitive, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a standard pharmaceutical supply transaction under...